for the Period Ended 30 September 2024
| Directors report | |
| Profit and loss | |
| Balance sheet | |
| Additional notes | |
| Balance sheet notes | |
| Community Interest Report |
Directors' report period ended
The directors present their report with the financial statements of the company for the period ended 30 September 2024
Principal activities of the company
Directors
The director shown below has held office during the whole of the period from
1 October 2023
to
30 September 2024
The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006
This report was approved by the board of directors on
And signed on behalf of the board by:
Name:
Status: Director
for the Period Ended
| 2024 | 2023 | |
|---|---|---|
|
|
£ |
£ |
| Turnover: |
|
|
| Cost of sales: |
(
|
(
|
| Gross profit(or loss): |
|
|
| Administrative expenses: |
(
|
(
|
| Other operating income: |
|
|
| Operating profit(or loss): |
|
|
| Profit(or loss) before tax: |
|
|
| Profit(or loss) for the financial year: |
|
|
As at
| Notes | 2024 | 2023 | |
|---|---|---|---|
|
|
£ |
£ |
|
| Fixed assets | |||
| Intangible assets: | 3 |
|
|
| Tangible assets: |
|
|
|
| Investments: |
|
|
|
| Total fixed assets: |
|
|
|
| Current assets | |||
| Stocks: |
|
||
| Debtors: |
|
||
| Cash at bank and in hand: |
|
|
|
| Investments: |
|
||
| Total current assets: |
|
|
|
| Prepayments and accrued income: |
|
|
|
| Creditors: amounts falling due within one year: |
|
|
|
| Net current assets (liabilities): |
|
|
|
| Total assets less current liabilities: |
|
|
|
| Creditors: amounts falling due after more than one year: |
|
|
|
| Provision for liabilities: |
|
|
|
| Accruals and deferred income: |
|
|
|
| Total net assets (liabilities): |
|
|
|
| Capital and reserves | |||
| Called up share capital: |
|
|
|
| Share premium account: |
|
|
|
| Other reserves: |
|
|
|
| Profit and loss account: |
|
|
|
| Total Shareholders' funds: |
|
|
The notes form part of these financial statements
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 30 September 2024
Basis of measurement and preparation
for the Period Ended 30 September 2024
| 2024 | 2023 | |
|---|---|---|
| Average number of employees during the period |
|
|
for the Period Ended 30 September 2024
| Goodwill | Other | Total | |
|---|---|---|---|
| Cost | £ | £ | £ |
| At 1 October 2023 |
|
|
|
| Additions |
|
|
|
| Disposals |
|
|
|
| Revaluations |
|
|
|
| Transfers |
|
|
|
| At 30 September 2024 |
|
|
|
| Amortisation | |||
| At 1 October 2023 |
|
|
|
| Charge for year |
|
|
|
| On disposals |
|
|
|
| Other adjustments |
|
|
|
| At 30 September 2024 |
|
|
|
| Net book value | |||
| At 30 September 2024 |
|
|
|
| At 30 September 2023 |
|
|
|
The Charity Has provided support in the following areas To provide support for children, parents and family impacted by sickle cell disease. Supporting local businesses, hospitals and businesses as well as educational establishments in regards to awareness support, for sickle cell patients within their care. Raising awareness to ethnically matched blood donors needed for sickle cell patients needing blood transfusions for a better quality of life. Providing those with sickle cell disease a voice to talk about living with the condition without stigma or prejudice.
No consultation with stakeholders
No remuneration was received
No transfer of assets other than for full consideration
This report was approved by the board of directors on
25 September 2025
And signed on behalf of the board by:
Name: Kehinde Salami
Status: Director